CENPE and lung carcinoma: In lung cancer models specifically, CENPE inhibition has shown promising synergistic effects when combined with Navitoclax, a BH3-mimetic that inhibits anti-apoptotic proteins, as well as MEK/ERK inhibitors [120,130,131].